Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Immatics N.V. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 50 | 51 | +1 |
| Shares | 21.0M | 22.5M | +1.44M (+6.8%) |
| Value | $243.4M | $292.1M | +$48.7M (+20.0%) |
New holders (7)
Institutions that held Immatics N.V. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sphera Funds Management Ltd. | 800,043 | $10.4M | 1.03% |
| Marshall Wace North America L.P. | 69,188 | $899.0K | 0.00% |
| Alpha Paradigm Partners, LLC | 15,909 | $207.0K | 0.08% |
| MYDA Advisors LLC | 10,000 | $130.0K | 0.05% |
| Copernicus Capital Management, LLC | 10,000 | $130.0K | 1.57% |
| Belvedere Trading LLC | 3,006 | $40.0K | 0.01% |
| Royal Bank of Canada | 2 | $0 | 0.00% |
Sold out (6)
Institutions that held Immatics N.V. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| DSAM Partners (London) Ltd | 152,990 | $1.78M |
| Maven Securities LTD | 101,245 | $1.18M |
| HighTower Advisors, LLC | 30,000 | $348.0K |
| Fort Baker Capital Management LP | 99,077 | $340.0K |
| LPL Financial LLC | 13,043 | $151.0K |
| California Public Employees Retirement System | 10,804 | $125.0K |